skip to content

Office for Translational Research

 

The EMI Steering Committee manages the strategic direction of the programme and makes decisions in relation to its operational aspects. The Committee meets annually to:

  • Review Expressions of Interest (EoIs) for research projects
  • Review recruitment and progress for EMI trainees and clinical lecturers
  • Review, propose and manage training events and opportunities (via the Training Sub-committee, listed below).

 

Steering Committee

Prof Ian Wilkinson (Chair) - Head of the Division of Experimental Medicine and Immunotherapeutics - EMI Programme Director
Dr Ben Challis - AstraZeneca industry partner - Co-director of the EMI Programme
Dr Nicolas Wisniacki  - GlaxoSmithKline industry partner - Co-director of the EMI Programme
Dr Nicola White (Secretary) - EMI Programme Manager
Prof David Jayne - Division of Experimental Medicine and Immunotherapeutics
Prof Duncan Jodrell - Department of Oncology
Prof Sadaf Farooqi – Institute of Metabolic Science Metabolic Research Laboratories 
Dr Carmel McEniery – Division of Experimental Medicine and Immunotherapeutics
Dr Ferdia Gallagher – Department of Radiology
Dr Joseph Cheriyan - Division of Experimental Medicine and Immunotherapeutics
Dr Mark Evans – Institute of Metabolic Science Metabolic Research Laboratories
Dr Menna Clatworthy – NIHR Cambridge Biomedical Research Centre
Dr Mike Allison – Cambridge University Hospitals Trust
Mrs Elizabeth McIntyre – Graduate and Clinical Academic Training

 

Training Sub-committee

Dr Joseph Cheriyan (Chair) - Division of Experimental Medicine and Immunotherapeutics
Prof Ian Wilkinson - Head of Division of Experimental Medicine and Immunotherapeutics
Dr Ben Challis - AstraZeneca industry partner
Dr Phil Ambery - AstraZeneca, Global Clinical Leader in Diabetes
Mrs Elizabeth McIntyre - Graduate and Clinical Academic Training